Valentina Costantino
Overview
Explore the profile of Valentina Costantino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Costantino V, Grafton Q, Kompas T, Chu L, Honeyman D, Notaras A, et al.
Med J Aust
. 2024 Aug;
221(4):217-223.
PMID: 39154292
Objective: To estimate the number of people in Australia with long COVID by age group, and the associated medium term productivity and economic losses. Study Design: Modelling study: a susceptible-exposed-infected-recovered...
2.
Costantino V, MacIntyre C
Sci Rep
. 2024 Jun;
14(1):14729.
PMID: 38926448
COVID-19 surveillance in Ukraine ceased after the Russian invasion of the country in 2022, on a background of low vaccination rates of 34.5% for two doses at this time. We...
3.
Moa A, Kunasekaran M, Akhtar Z, Costantino V, MacIntyre C
Hum Vaccin Immunother
. 2023 Nov;
19(3):2271304.
PMID: 37929779
We estimated the effectiveness of influenza vaccines in preventing laboratory-confirmed influenza among older adults in aged care. Electronic database searches were conducted using search terms, and studies were selected as...
4.
MacIntyre C, Kevin Yin J, Felter C, Menzies R, Thommes E, Largeron N, et al.
Vaccine X
. 2023 Aug;
15:100365.
PMID: 37609557
Background: Standard dose influenza vaccine provides moderate protection from infection, but with lower effectiveness among the elderly. High dose and adjuvanted vaccines (HD-TIV and aTIV) were developed to address this....
5.
Costantino V, Bahl P, Doolan C, de Silva C, Heslop D, Chen X, et al.
Health Secur
. 2023 Jan;
21(1):61-69.
PMID: 36695665
This study aimed to determine optimal mitigation strategies in the event of an aerosolized attack with , a category A bioterrorism agent with a case fatality rate of nearly 100%...
6.
Carone M, Alpe D, Costantino V, Derossi C, Occhipinti A, Zanetti M, et al.
Chemosphere
. 2022 Jul;
307(Pt 2):135755.
PMID: 35868532
Microalgae-based biorefinery processes are gaining particular importance as a biotechnological tool for direct carbon dioxide fixation and production of high-quality biomass and energy feedstock for different industrial markets. However, despite...
7.
MacIntyre C, Costantino V, Chanmugam A
Vaccine
. 2021 Sep;
39(42):6296-6301.
PMID: 34538699
Face masks were mandated in New York during the first wave in 2020, and in 2021 the first vaccine programs have commenced. We aimed to examine the impact of face...
8.
Costantino V, MacIntyre C
Front Public Health
. 2021 May;
9:625499.
PMID: 33968879
To estimate the impact of universal community face mask use in Victoria, Australia along with other routine disease control measures in place. A mathematical modeling study using an age structured...
9.
MacIntyre C, Costantino V, Trent M
Vaccine
. 2021 May;
40(17):2506-2513.
PMID: 33958223
Several vaccines for SARS-CoV-2 are expected to be available in Australia in 2021. Initial supply is limited and will require a judicious vaccination strategy until supply is unrestricted. If vaccines...
10.
Nguyen P, Ajisegiri W, Costantino V, Chughtai A, MacIntyre C
Emerg Infect Dis
. 2021 Mar;
27(4).
PMID: 33756100
A monkeypox outbreak in Nigeria during 2017-2020 provides an illustrative case study for emerging zoonoses. We built a statistical model to simulate declining immunity from monkeypox at 2 levels: At...